Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, by Delivering Full Strength of the Drug via Intravenous InjectionSAN DIEGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback